Pelthos Therapeutics Inc.
PTHS
$23.42
-$1.13-4.60%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -86.39M | -51.59M | -43.32M | -23.58M | -9.04M |
| Total Depreciation and Amortization | 5.32M | 3.93M | 2.36M | 1.14M | -- |
| Total Amortization of Deferred Charges | 432.10K | 360.10K | 259.10K | 335.10K | 345.40K |
| Total Other Non-Cash Items | 44.25M | 21.48M | 24.18M | 6.30M | 1.58M |
| Change in Net Operating Assets | -5.91M | -9.26M | -6.07M | -1.20M | 5.18M |
| Cash from Operations | -42.30M | -35.08M | -22.59M | -17.01M | -1.93M |
| Capital Expenditure | -295.00K | -293.00K | -99.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -5.14M | -5.14M | -5.14M | 2.76M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -5.43M | -5.43M | -5.24M | 2.76M | -- |
| Total Debt Issued | 47.30M | 47.68M | 18.59M | 539.00K | -426.30K |
| Total Debt Repaid | -2.66M | -2.66M | -845.00K | -845.00K | -200.00 |
| Issuance of Common Stock | 206.00K | 206.00K | 206.00K | 168.00K | 83.00K |
| Repurchase of Common Stock | -- | -- | -- | -75.00K | -75.00K |
| Issuance of Preferred Stock | 27.38M | 27.38M | 27.38M | 27.38M | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 74.00K | -500.00 |
| Cash from Financing | 72.23M | 72.61M | 45.34M | 27.25M | -419.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 24.50M | 32.10M | 17.51M | 13.00M | -2.35M |